The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Saturday announced agreement with a research group consortium led by Elekta (EKTAB) and Royal Philips Electronics (PHG, PHIA) to join to advance the development of image-guided treatment technology for cancer care.
The fairly new technology merges radiation therapy and magnetic resonance imaging technology in a single system, providing physicians with exceptional images of a patient's soft tissues and tumor during radiation therapy.
This breakthrough innovation also aims to permit clinicians to adapt treatment delivery in real time for the most precise cancer treatments possible. MRI-guided radiotherapy allows optimal imaging and will therefore improve the accuracy of our treatment delivery.
"MRI has steadily revolutionized healthcare since its introduction nearly three decades ago, giving clinicians unparalleled views of soft tissues and pathology," says Tomas Puusepp, Elekta President and CEO.
Elekta and Philips, along with the University Medical Center Utrecht have previously tested a prototype system that integrates a linear accelerator and a 1.5 Tesla MRI system.
For comments and feedback: editorial@rttnews.com